Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Response to 'A missing pebble in the mosaic of rheumatic diseases and mental health: younger does not always mean happier' by Alunno et al.

Redeker I, Hoffmann F, Callhoff J, Haibel H, Sieper J, Zink A, Poddubnyy D.

Ann Rheum Dis. 2018 May 31. pii: annrheumdis-2018-213620. doi: 10.1136/annrheumdis-2018-213620. [Epub ahead of print] No abstract available.

PMID:
29853451
2.

[Research consortium Neuroimmunology and pain in the research network musculoskeletal diseases].

Schaible HG, Chang HD, Grässel S, Haibel H, Hess A, Kamradt T, Radbruch A, Schett G, Stein C, Straub RH.

Z Rheumatol. 2018 May;77(Suppl 1):24-30. doi: 10.1007/s00393-018-0459-9. Review. German.

PMID:
29654392
3.

Determinants of psychological well-being in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data.

Redeker I, Hoffmann F, Callhoff J, Haibel H, Sieper J, Zink A, Poddubnyy D.

Ann Rheum Dis. 2018 Jul;77(7):1017-1024. doi: 10.1136/annrheumdis-2017-212629. Epub 2018 Mar 10.

4.

Functional relevance of radiographic spinal progression in axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort.

Poddubnyy D, Listing J, Haibel H, Knüppel S, Rudwaleit M, Sieper J.

Rheumatology (Oxford). 2018 Apr 1;57(4):703-711. doi: 10.1093/rheumatology/kex475.

PMID:
29373733
5.

Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.

Protopopov M, Sieper J, Haibel H, Listing J, Rudwaleit M, Poddubnyy D.

Arthritis Res Ther. 2017 Oct 24;19(1):240. doi: 10.1186/s13075-017-1453-3.

6.

Chronic meningococcaemia-a medical oxymoron.

Rademacher J, Haibel H, Poddubnyy D, Ignatius R, Schneider T.

Rheumatology (Oxford). 2017 Oct 1;56(10):1819-1821. doi: 10.1093/rheumatology/kex219. No abstract available.

PMID:
28957545
7.

Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.

Poddubnyy D, Fedorova A, Listing J, Haibel H, Baraliakos X, Braun J, Sieper J.

J Rheumatol. 2016 Dec;43(12):2142-2148. Epub 2016 Nov 1.

PMID:
27803139
8.

[Treat-to-target (T2T) recommendation for patients with spondyloarthritis - translation into German].

Kiltz U, Sieper J, Backhaus M, Buss B, Gromnica-Ihle E, Haíbel H, Hammel L, Karberg K, Rehart S, Rudwaleit M, Schuch F, Steffens-Korbanka P, Braun J.

Z Rheumatol. 2016 Nov;75(9):903-909. German.

PMID:
27488447
9.

High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort.

Poddubnyy D, Protopopov M, Haibel H, Braun J, Rudwaleit M, Sieper J.

Ann Rheum Dis. 2016 Dec;75(12):2114-2118. doi: 10.1136/annrheumdis-2016-209209. Epub 2016 Apr 28.

PMID:
27125522
10.

Comparison of Clinical Examination versus Whole-body Magnetic Resonance Imaging of Enthesitis in Patients with Early Axial Spondyloarthritis during 3 Years of Continuous Etanercept Treatment.

Althoff CE, Sieper J, Song IH, Weiß A, Diekhoff T, Haibel H, Hamm B, Hermann KG.

J Rheumatol. 2016 Mar;43(3):618-24. doi: 10.3899/jrheum.150659. Epub 2016 Feb 1.

PMID:
26834218
11.

Inflammatory and fatty lesions in the spine and sacroiliac joints on whole-body MRI in early axial spondyloarthritis--3-Year data of the ESTHER trial.

Song IH, Hermann KG, Haibel H, Althoff CE, Poddubnyy D, Listing J, Weiß A, Freundlich B, Lange E, Rudwaleit M, Sieper J.

Semin Arthritis Rheum. 2016 Feb;45(4):404-10. doi: 10.1016/j.semarthrit.2015.08.005. Epub 2015 Sep 4.

PMID:
26519007
13.

[Enthesitis in connection with spondyloarthritides].

Haibel H, Sieper J.

Orthopade. 2015 May;44(5):395-404; quiz 405-6. doi: 10.1007/s00132-015-3114-z. German.

PMID:
25920504
14.

[Enthesitis in the context of spondyloarthritides].

Haibel H, Sieper J.

Z Rheumatol. 2015 Feb;74(1):39-48; quiz 49-50. doi: 10.1007/s00393-014-1475-z. German.

PMID:
25608675
15.

Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progression.

Syrbe U, Callhoff J, Conrad K, Poddubnyy D, Haibel H, Junker S, Frommer KW, Müller-Ladner U, Neumann E, Sieper J.

Arthritis Rheumatol. 2015 Mar;67(3):678-85. doi: 10.1002/art.38968.

16.

Prevention of new osteitis on magnetic resonance imaging in patients with early axial spondyloarthritis during 3 years of continuous treatment with etanercept: data of the ESTHER trial.

Song IH, Hermann KG, Haibel H, Althoff CE, Poddubnyy D, Listing J, Weiß A, Lange E, Freundlich B, Rudwaleit M, Sieper J.

Rheumatology (Oxford). 2015 Feb;54(2):257-61. doi: 10.1093/rheumatology/keu263. Epub 2014 Aug 19.

PMID:
25140041
17.

Consistently Good clinical response in patients with early axial spondyloarthritis after 3 years of continuous treatment with etanercept: longterm data of the ESTHER trial.

Song IH, Hermann KG, Haibel H, Althoff CE, Poddubnyy D, Listing J, Weiß A, Buß B, Freundlich B, Lange E, Alten R, Rudwaleit M, Sieper J.

J Rheumatol. 2014 Oct;41(10):2034-40. doi: 10.3899/jrheum.140056. Epub 2014 Jul 15.

PMID:
25028375
18.

Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis.

Turina MC, Sieper J, Yeremenko N, Conrad K, Haibel H, Rudwaleit M, Baeten D, Poddubnyy D.

Ann Rheum Dis. 2014 Sep;73(9):1746-8. doi: 10.1136/annrheumdis-2014-205506. Epub 2014 May 20. No abstract available.

PMID:
24845387
20.

Withdrawal of biologic therapy in axial spondyloarthritis: the experience in early disease.

Song IH, Haibel H, Poddubnyy D, Braun J, Sieper J.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S37-42. Epub 2013 Oct 3. Review.

PMID:
24129135
21.

Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritis.

Poddubnyy D, Conrad K, Haibel H, Syrbe U, Appel H, Braun J, Rudwaleit M, Sieper J.

Ann Rheum Dis. 2014 Dec;73(12):2137-43. doi: 10.1136/annrheumdis-2013-203824. Epub 2013 Aug 16.

PMID:
23956246
22.

Vertebral erosions associated with spinal inflammation in patients with ankylosing spondylitis identified by magnetic resonance imaging: changes after 2 years of tumor necrosis factor inhibitor therapy.

Baraliakos X, Listing J, Haibel H, Sieper J, Braun J.

J Rheumatol. 2013 Nov;40(11):1891-6. doi: 10.3899/jrheum.120533. Epub 2013 Aug 1.

PMID:
23908444
23.

Magnetic resonance imaging compared to conventional radiographs for detection of chronic structural changes in sacroiliac joints in axial spondyloarthritis.

Poddubnyy D, Gaydukova I, Hermann KG, Song IH, Haibel H, Braun J, Sieper J.

J Rheumatol. 2013 Sep;40(9):1557-65. doi: 10.3899/jrheum.130141. Epub 2013 Jul 1.

PMID:
23818713
24.

Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years.

Baraliakos X, Haibel H, Fritz C, Listing J, Heldmann F, Braun J, Sieper J.

Arthritis Res Ther. 2013;15(3):R67.

25.

Long-term efficacy of adalimumab after drug withdrawal and retreatment in patients with active non-radiographically evident axial spondyloarthritis who experience a flare.

Haibel H, Heldmann F, Braun J, Listing J, Kupper H, Sieper J.

Arthritis Rheum. 2013 Aug;65(8):2211-3. doi: 10.1002/art.38014. No abstract available.

26.

Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial.

Haibel H, Fendler C, Listing J, Callhoff J, Braun J, Sieper J.

Ann Rheum Dis. 2014 Jan;73(1):243-6. doi: 10.1136/annrheumdis-2012-203055. Epub 2013 Apr 26.

PMID:
23625982
27.

Cigarette smoking has a dose-dependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort (GESPIC).

Poddubnyy D, Haibel H, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J, Rudwaleit M.

Ann Rheum Dis. 2013 Aug;72(8):1430-2. doi: 10.1136/annrheumdis-2012-203148. Epub 2013 Apr 26. No abstract available.

PMID:
23625981
28.

Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis.

Baraliakos X, Haibel H, Listing J, Sieper J, Braun J.

Ann Rheum Dis. 2014 Apr;73(4):710-5. doi: 10.1136/annrheumdis-2012-202698. Epub 2013 Mar 16.

PMID:
23505240
29.

Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.

Song IH, Weiß A, Hermann KG, Haibel H, Althoff CE, Poddubnyy D, Listing J, Lange E, Freundlich B, Rudwaleit M, Sieper J.

Ann Rheum Dis. 2013 Jun;72(6):823-5. doi: 10.1136/annrheumdis-2012-202389. Epub 2012 Nov 21.

PMID:
23172749
30.

Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI.

Althoff CE, Sieper J, Song IH, Haibel H, Weiß A, Diekhoff T, Rudwaleit M, Freundlich B, Hamm B, Hermann KG.

Ann Rheum Dis. 2013 Jun;72(6):967-73. doi: 10.1136/annrheumdis-2012-201545. Epub 2012 Jun 26.

PMID:
22736088
31.

Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.

Poddubnyy D, Rudwaleit M, Haibel H, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J.

Ann Rheum Dis. 2012 Oct;71(10):1616-22. doi: 10.1136/annrheumdis-2011-201252. Epub 2012 Mar 29.

PMID:
22459541
32.

Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial.

Song IH, Althoff CE, Haibel H, Hermann KG, Poddubnyy D, Listing J, Weiß A, Djacenko S, Burmester GR, Bohl-Bühler M, Freundlich B, Rudwaleit M, Sieper J.

Ann Rheum Dis. 2012 Jul;71(7):1212-5. doi: 10.1136/annrheumdis-2011-201010. Epub 2012 Mar 22.

PMID:
22440819
33.

High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis.

Heiland GR, Appel H, Poddubnyy D, Zwerina J, Hueber A, Haibel H, Baraliakos X, Listing J, Rudwaleit M, Schett G, Sieper J.

Ann Rheum Dis. 2012 Apr;71(4):572-4. doi: 10.1136/annrheumdis-2011-200216. Epub 2011 Dec 20.

PMID:
22186710
34.

Evaluation of the spinal pain score in AS--a psychometric analysis.

Song IH, Haibel H, Stelling ES, Sieper J, Rudwaleit M.

Rheumatology (Oxford). 2012 Dec;51(12):2155-63. doi: 10.1093/rheumatology/ker347. Epub 2011 Dec 11.

PMID:
22157684
35.

Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis.

Poddubnyy D, Haibel H, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J, Rudwaleit M.

Arthritis Rheum. 2012 May;64(5):1388-98. doi: 10.1002/art.33465.

36.

Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years--early clinical response predicts long-term outcome.

Baraliakos X, Listing J, Fritz C, Haibel H, Alten R, Burmester GR, Krause A, Schewe S, Schneider M, Sörensen H, Schmidt R, Sieper J, Braun J.

Rheumatology (Oxford). 2011 Sep;50(9):1690-9. doi: 10.1093/rheumatology/ker194. Epub 2011 Jun 14.

PMID:
21672969
37.

Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis.

Poddubnyy D, Rudwaleit M, Haibel H, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J.

Ann Rheum Dis. 2011 Aug;70(8):1369-74. doi: 10.1136/ard.2010.145995. Epub 2011 May 27.

PMID:
21622969
38.

Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48.

Song IH, Hermann KG, Haibel H, Althoff CE, Poddubnyy D, Listing J, Weiss A, Freundlich B, Rudwaleit M, Sieper J.

Ann Rheum Dis. 2011 Jul;70(7):1257-63. doi: 10.1136/ard.2010.147033. Epub 2011 May 8.

39.

Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study.

Song IH, Heldmann F, Rudwaleit M, Haibel H, Weiss A, Braun J, Sieper J.

Ann Rheum Dis. 2011 Jun;70(6):1108-10. doi: 10.1136/ard.2010.145946. Epub 2011 Mar 17.

PMID:
21415053
40.

Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial.

Song IH, Hermann K, Haibel H, Althoff CE, Listing J, Burmester G, Krause A, Bohl-Bühler M, Freundlich B, Rudwaleit M, Sieper J.

Ann Rheum Dis. 2011 Apr;70(4):590-6. doi: 10.1136/ard.2010.139667. Erratum in: Ann Rheum Dis. 2011 Jul;70(7):1350. Althoff, Ce [corrected to Althoff, C E].

41.

Use of methotrexate in patients with ankylosing spondylitis.

Haibel H, Sieper J.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 61):S128-31. Epub 2010 Oct 28. Review.

PMID:
21044446
42.

Editorial review: how early should ankylosing spondylitis be treated with a tumor necrosis factor-blocker?

Haibel H, Sieper J.

Curr Opin Rheumatol. 2010 Jul;22(4):388-92. doi: 10.1097/BOR.0b013e32833aaf93. Review.

PMID:
20473176
43.

Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis.

Haibel H, Specker C.

Clin Exp Rheumatol. 2009 Jul-Aug;27(4 Suppl 55):S159-63. Review.

PMID:
19822065
44.

Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis.

Appel H, Ruiz-Heiland G, Listing J, Zwerina J, Herrmann M, Mueller R, Haibel H, Baraliakos X, Hempfing A, Rudwaleit M, Sieper J, Schett G.

Arthritis Rheum. 2009 Nov;60(11):3257-62. doi: 10.1002/art.24888.

45.

The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort.

Rudwaleit M, Haibel H, Baraliakos X, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J.

Arthritis Rheum. 2009 Mar;60(3):717-27. doi: 10.1002/art.24483.

46.
47.

Multicenter open-label study with infliximab in active ankylosing spondylitis over 28 weeks in daily practice.

Haibel H, Song IH, Rudwaleit M, Listing J, Hildemann S, Sieper J.

Clin Exp Rheumatol. 2008 Mar-Apr;26(2):247-52.

PMID:
18565245
48.

New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept.

Song IH, Appel H, Haibel H, Loddenkemper C, Braun J, Sieper J, Rudwaleit M.

J Rheumatol. 2008 Mar;35(3):532-6. Epub 2008 Jan 15. Erratum in: J Rheumatol. 2008 Apr;35(4):729.

PMID:
18203308
49.

In vitro observations of T cell responsiveness to recall antigens during tumor necrosis factor-alpha-blocking therapy in patients with ankylosing spondylitis.

Appel H, Scheer R, Haibel H, Wu P, Spiller I, Brandt H, Song IH, Rudwaleit M, Thiel A, Sieper J.

J Rheumatol. 2007 Nov;34(11):2264-70. Epub 2007 Oct 1.

PMID:
17918784
50.

Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab.

Baraliakos X, Listing J, Brandt J, Haibel H, Rudwaleit M, Sieper J, Braun J.

Rheumatology (Oxford). 2007 Sep;46(9):1450-3. Epub 2007 Jul 10.

PMID:
17623745

Supplemental Content

Loading ...
Support Center